Values First Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$260K Sell
2,282
-70
-3% -$8.25K 0.12% 160
2026
Q2
$251K Buy
2,352
+149
+7% +$18K 0.11% 160
2026
Q1
$360K Buy
2,203
+146
+7% +$22.4K 0.19% 123
2025
Q4
$358K Sell
2,057
-3,409
-62% -$622K 0.19% 124
2025
Q3
$787K Sell
5,466
-245
-4% -$30K 0.42% 67
2025
Q2
$575K Buy
5,711
+474
+9% +$36.2K 0.31% 91
2025
Q1
$401K Buy
5,237
+38
+0.7% +$2.91K 0.23% 117
2024
Q4
$359K Buy
5,199
+221
+4% +$15.9K 0.2% 120
2024
Q3
$363K Buy
+4,978
New +$367K 0.2% 113
2023
Q2
– Sell
-3,320
Closed -$56.6K – 243
2023
Q1
$56.6K Buy
+3,320
New +$64.5K 0.04% 185

Other funds holding INSM

Values First Advisors's INSM Position: Q3 2026 in Review

Values First Advisors reduced its Insmed (INSM) stake by 3% in Q3 2026, selling an estimated $8.25K and leaving 2,282 shares worth $260K. The position accounts for 0.12% of the portfolio, ranked #160.

Values First Advisors first reported a position in INSM in Q1 2023 and has held it in 10 quarters since. The position peaked at $787K in Q3 2025. 176 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Values First Advisors held 2,282 shares of Insmed worth $260K as of Q3 2026.
  • Values First Advisors sold 70 Insmed shares in Q3 2026, an estimated $8.25K.
  • Insmed made up 0.12% of Values First Advisors's portfolio in Q3 2026, its #160 holding.
  • Values First Advisors first reported a position in Insmed in Q1 2023 and has held it in 10 quarters since.
  • Values First Advisors's Insmed position peaked at $787K in Q3 2025.
  • 176 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Values First Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.